Skip to content

Evaluation of the injection of umbilical cord-derived stem cells and platelet-rich plasma in patients with resistant lateral epicondylitis in patients referred to the super-specialized orthopedic clinic of Imam Khomeini Hospital in Sari

Evaluation of the injection of umbilical cord-derived stem cells and platelet-rich plasma in patients with resistant lateral epicondylitis in patients referred to the super-specialized orthopedic clinic of Imam Khomeini Hospital in Sari

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231206060276N1
Enrollment
24
Registered
2024-05-20
Start date
2024-04-16
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medial epicondylitis. Medial epicondylitis

Interventions

Intervention 1: Group 1: In the group where PRP injection is performed, the amount of injection is 2 cc. In order to prepare platelet-rich plasma, the blood sample is poured into a tube containing the

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients in the age group of 20 to 60 years with pain and limitation of elbow movement, whose symptoms have been present for more than 3 months and did not respond to non-surgical treatment and corticosteroid injection for 6 to 12 months. It is considered as a chronic type and resistant to treatment. Failure to respond to drug and physiotherapy treatment Recurrence of the disease

Exclusion criteria

Exclusion criteria: Patients with a history of elbow arthritis and a history of elbow fracture Patients who have a history of elbow surgery Patients with systemic blood problems

Design outcomes

Primary

MeasureTime frame
GRIP Score. Timepoint: The fourth week, the eighth week, the third month, and the sixth month. Method of measurement: dynamometer.;The amount of pain. Timepoint: The fourth week, the eighth week, the third month, and the sixth month. Method of measurement: Visual Analogue Scale.;Range of motion. Timepoint: The fourth week, the eighth week, the third month, and the sixth month. Method of measurement: Patient Rated Tennis Elboow Evaluation.

Secondary

MeasureTime frame
Quality of life score - pain reduction score. Timepoint: It is evaluated at different intervals of the fourth week, the eighth week, the third month, and the sixth month. Method of measurement: Dynamometer and questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehran Razavipour

Mazandaran University of Medical Sciences

m.razavipour@mazums.ac.ir+98 11 3336 1700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026